Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study June 2025 Congress News Read more
2020 April Corona Intelligent algorithm from Singapore identifies 18 potential treatments for people with COVID-... Read more
2020 April Clinical practice High biotin concentration in blood can be a cause of misdiagnosis Read more
2020 April Science Lower microbiota diversity linked to higher mortality in stem cell transplant patients Read more
2020 April Pharma News Luspatercept can reduce transfusion need in patients with MDS and β-thalassemia Read more
Top
